Precision Business Insights


Restless Legs Syndrome Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Restless Legs Syndrome Market By Medication Type (Antihistamines , Anti-nausea drugs , Antipsychotic drugs, Selective Serotonin Reuptake Inhibitors (SSRIs), Tricyclic Antidepressants, Others), By End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography


Market Outline: Restless Legs Syndrome Market

Restless legs syndrome (RLS), otherwise called Willis-Ekbom infection, is a condition that causes awkward sensations, regularly in the legs. These sensations have been portrayed as tingly, slithering, disturbing sensations, and make the staggering urge move the influenced appendage. RLS side effects commonly happen when the individual is sitting, resting, or dozing, and regularly occur around evening time. The developments caused by RLS are called periodic limb movements of sleep (PLMS). On account of these developments, RLS can cause serious sleep issues.


Market Dynamics: Restless Legs Syndrome Market 

The higher predominance of restless legs syndrome is noted in ladies than in men. RLS can influence individuals everything being equal yet is for the most part seen in moderately aged and elderly individuals. The most well-known manifestations of RLS incorporate awkward tingling and torment in the legs that may cause a disturbance in the rest design and at last influence a patient’s personal satisfaction. In spite of its expanding commonness, the exact reason for RLS isn’t yet known. Nevertheless, with broad examinations being led in the field, the RLS market is relied upon to pick up energy sooner rather than later. Starting at now, specialists quality the expanding occurrence of the malady to hereditary elements and insecurities in the dopaminergic adjust.


Market Scope

The Restless Legs Syndrome Market is classified on the basis of medication type, end user and geographical regions.


Based on Medication Type, Restless Legs Syndrome Market is segmented into

  • Antihistamines
  • Anti-nausea drugs
  • Antipsychotic drugs
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Tricyclic Antidepressants
  • Others

Based on End User, Restless Legs Syndrome Market is segmented into

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies




North America

  • US
  • Canada


  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe


  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA


Market Summary: Restless Legs Syndrome Market 

The presently accessible medications in restless legs syndrome can just conveyed to target particular patients for symptomatic alleviation as it were. Also, a portion of the unfriendly impacts, for example, sensory system issue that incorporate migraine, dazedness, sedation, sickness, fart and dry mouth. Mental disarranges, including diminished charisma and wretchedness. Digestion and healthful issue, including expanded hunger and weight pick up; ear issue, maze issue and other normal issue, for example, peevishness, exhaustion, and fringe edema are connected with the utilization of these medications. In this way the treatment methodology for the fretful legs disorder is as yet not extremely famous and not embraced by the medicinal services specialist co-op on a bigger part. The improvement of new medications that have higher productivity and the insignificant reaction would be exceedingly refreshing in the restless legs syndrome market.


Regional Analysis: Restless Legs Syndrome Market 

Geographically Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe.  Market is dominated by North America followed by Europe due to the increasing prevalence of Restless Legs Syndrome and well established healthcare infrastructure in those regions. Due to the increase in adoption of various treatment options, growing health concerns are the factors which are supporting the Asia Pacific regions such as India and China to show a significant growth in the Restless Legs Syndrome Market.


Market participants

  • Biogen, Inc (U.S).
  • Pfizer, Inc. (U.s)
  • Johnson & Johnson Services, Inc. (U.S)
  • Eli Lilly & Company (U.S)
  • Merck & Co., Inc. (U.S)
  • AstraZeneca (UK)
  • Novartis AG (Switzerland)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Shire Plc. (Ireland)
  • GlaxoSmithKline (UK)